Related references
Note: Only part of the references are listed.Advances in structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2017)
Synthesis, Biological Evaluation, and Docking Studies of a Novel Sulfonamido-Based Gallate as Pro-Chondrogenic Agent for the Treatment of Cartilage
Xiao Lin et al.
MOLECULES (2017)
Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents
Martin Kratky et al.
MOLECULES (2017)
Secondary Sulfonamides as Effective Lactoperoxidase Inhibitors
Zeynep Koksal et al.
MOLECULES (2017)
Optimization and Comparison of Synthetic Procedures for a Group of Triazinyl-Substituted Benzene-Sulfonamide Conjugates with Amino Acids
Dominika Krajciova et al.
MOLECULES (2017)
Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives
Krzysztof Marciniec et al.
MOLECULES (2017)
N-Pyrrylarylsulfones with High Therapeutic Potential
Valeria Famiglini et al.
MOLECULES (2017)
Comparison of the Sulfonamide Inhibition Profiles of the - and -Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei
Daniela Vullo et al.
MOLECULES (2017)
Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking
Pervaiz Ali Channar et al.
MOLECULES (2017)
Novel Sulfamide-Containing Compounds as Selective Carbonic Anhydrase I Inhibitors
Emanuela Berrino et al.
MOLECULES (2017)
Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors
Claudiu T. Supuran
METABOLITES (2017)
How many carbonic anhydrase inhibition mechanisms exist?
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Bacterial, fungal and protozoan carbonic anhydrases as drug targets
Clemente Capasso et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
Sulfonamides and their isosters as carbonic anhydrase inhibitors
Fabrizio Carta et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
Clemente Capasso et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Secondary and tertiary sulfonamides: a patent review (2008-2012)
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiglaucoma carbonic anhydrase inhibitors: a patent review
Emanuela Masini et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)
Simona Maria Monti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005-2013)
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Sulfonamides: a patent review (2008-2012)
Fabrizio Carta et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Structure-based drug discovery of carbonic anhydrase inhibitors
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency
Fabio Pacchiano et al.
CHEMICAL COMMUNICATIONS (2010)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases
Sabrina A. Zimmerman et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
The sulfamide motif in the design of enzyme inhibitors
JY Winum et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2006)
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes
L Puccetti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX
V Garaj et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Metal binding and antibacterial activity of ciprofloxacin complexes
ZH Chohan et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2005)
Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase
F Abbate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
V Garaj et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Anticancer and antiviral sulfonamides
A Scozzafava et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties
A Scozzafava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Carbonic anhydrase inhibitors: Perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action
A Scozzafava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Carbonic anhydrase and matrix metalloproteinase inhibitors:: Sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes
A Scozzafava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Protease inhibitors:: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties
A Scozzafava et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)